F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 41 filers reported holding F-STAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,436,953 | -20.1% | 227,366 | -35.3% | 0.00% | – |
Q3 2022 | $1,798,000 | -34.2% | 351,336 | -19.5% | 0.00% | – |
Q2 2022 | $2,733,000 | +630.7% | 436,634 | +487.6% | 0.00% | – |
Q4 2021 | $374,000 | +29.0% | 74,302 | +87.6% | 0.00% | – |
Q3 2021 | $290,000 | +37.4% | 39,600 | +61.0% | 0.00% | – |
Q2 2021 | $211,000 | – | 24,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
Diametric Capital, LP | 44,449 | $228,000 | 0.12% |